Literature DB >> 29809277

How I treat older patients with acute myeloid leukemia.

Martha Arellano1, Jennifer Wilkinson Carlisle2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29809277     DOI: 10.1002/cncr.31347

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  What to use to treat AML: the role of emerging therapies.

Authors:  Felicitas Thol
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.

Authors:  Fabio Forghieri; Patrizia Comoli; Roberto Marasca; Leonardo Potenza; Mario Luppi
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 3.  Updates on the Management of Acute Myeloid Leukemia.

Authors:  Sofía Huerga-Domínguez; Sara Villar; Felipe Prósper; Ana Alfonso-Piérola
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

4.  Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.

Authors:  Xuelian Hu; Haodong Cai; Lu Zheng; Yi Luo; Jing Zhou; Yan Hui; Zhenyu Dai; Haolong Lin; Dengju Li; Yi Xiao; Liang Huang; Jianfeng Zhou
Journal:  Cancer Med       Date:  2020-05-18       Impact factor: 4.452

5.  HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia.

Authors:  Zhengchang He; Siyu Zhang; Dan Ma; Qin Fang; Liping Yang; Shaoxian Shen; Ying Chen; Lingli Ren; Jishi Wang
Journal:  J Transl Med       Date:  2019-11-11       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.